Cresco Labs (CRLBF) Divestments (2021 - 2025)

Cresco Labs' (CRLBF) quarterly Divestments came in at $213000.0 in Q4 2025, up 113.0% on a QoQ basis from $100000.0 in Q1 2025.

Cresco Labs (CRLBF) Divestments (2021 - 2025) Analysis & Trends

Cresco Labs (CRLBF) has 3 years of Divestments data on file, last reported at $213000.0 in Q4 2025.

Quarterly Divestments changed N/A year-over-year to $213000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 million, changed N/A from the prior year.
Divestments climbed to $213000.0 in Q4 2025, from $100000.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $2.7 million in Q1 2022 to a low of -$2.7 million in Q4 2022.
A 3-year average of $47750.0 and a median of $156500.0 in 2025 frame the typical range for Divestments.
The widest YoY moves for Divestments: up 3746.38% in 2022, down 37.44% in 2022.
Tracing CRLBF's Divestments over 3 years: stood at -$1.9 million in 2021, then plunged by 37.44% to -$2.7 million in 2022, then jumped by 108.03% to $213000.0 in 2025.
The last three Divestments figures came in at $213000.0 (Q4 2025), $100000.0 (Q1 2025), and -$2.7 million (Q4 2022), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Haleon	43.85 Bn	42.88 Bn	-	-
2	Teva Pharmaceutical Industries	43.02 Bn	39.37 Bn	2.15 Bn	4.00 Mn
3	Zoetis	31.47 Bn	29.79 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.59 Bn	22.79 Bn	5.10 Bn	65.64 Mn
5	United Therapeutics	22.20 Bn	19.53 Bn	683.80 Mn	-
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.45 Bn	15.06 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.10 Bn	9.94 Bn	-	-
10	Cresco Labs	290.46 Mn	226.34 Mn	86.95 Mn	-

Download Data